Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · Real-Time Price · USD

65.67

-1.85 (-2.74%)

At close: Aug 28, 2026, 4:00 PM EDT

65.21

-0.46 (-0.70%)

Pre-market: Aug 31, 2026, 5:11 AM EDT

Travere Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,190	3,419	1,516	676	1,350	1,900
Market Cap Growth	298.18%	125.49%	124.43%	-49.94%	-28.99%	36.59%
Enterprise Value	6,318	3,494	1,641	446	1,251	1,609
Last Close Price	65.67	38.21	17.42	8.99	21.03	31.04

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	16.74	38.08	42.85	42.85	42.85	42.85
PS Ratio	10.47	6.97	6.50	4.65	12.33	14.42
PB Ratio	252.20	29.77	25.66	3.36	31.49	6.29
P/TBV Ratio	-	3561.19	-	7.01	-	12.37
P/FCF Ratio	66.78	90.48	-	-	-	-
P/OCF Ratio	66.78	90.48	-	-	-	-
PEG Ratio	-	2.20	2.20	2.20	2.20	2.20

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	10.68	7.12	7.04	3.07	11.43	12.21
EV/FCF Ratio	68.15	92.47	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	25.16	2.86	6.80	2.02	9.51	0.87
Debt / EBITDA Ratio	22.59	141.76	-	-	-	-
Debt / FCF Ratio	6.66	8.70	-	-	-	-
Net Debt / Equity Ratio	5.21	0.05	0.52	-0.81	-1.00	-0.96
Net Debt / EBITDA Ratio	5.57	-2.85	-0.14	0.48	0.14	1.56
Net Debt / FCF Ratio	1.38	0.16	-0.13	0.58	0.23	14.62
Asset Turnover	0.87	0.82	0.34	0.20	0.15	0.19
Inventory Turnover	40.46	35.83	28.86	36.81	39.16	27.48
Quick Ratio	3.76	2.53	1.99	3.33	3.30	4.59
Current Ratio	4.05	2.74	2.08	3.47	3.42	4.70
Return on Equity (ROE)	-236.36%	-57.80%	-246.75%	-308.90%	-192.18%	-84.66%
Return on Assets (ROA)	-3.73%	-6.55%	-23.15%	-32.22%	-27.58%	-18.01%
Return on Capital Employed (ROCE)	-6.20%	-14.10%	-65.10%	-61.70%	-60.30%	-30.60%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-0.70%	-0.75%	-21.21%	-16.49%	-20.64%	-9.48%
FCF Yield	1.50%	1.10%	-15.66%	-41.45%	-13.80%	-1.05%
Buyback Yield / Dilution	-7.89%	-13.08%	-6.22%	-16.48%	-6.56%	-25.86%

SEC Filings: 10-K · 10-Q